共 70 条
[1]
Pui CH(2012)Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood 120 1165-1174
[2]
Mullighan CG(2015)Acute lymphoblastic leukemia in children N Engl J Med 373 1541-1552
[3]
Evans WE(2007)Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG) Blood 109 926-935
[4]
Relling MV(2001)Atlas of genetics and cytogenetics in oncology and hematology, updated Nucleic Acids Res 29 303-304
[5]
Hunger SP(2009)Karyotyping, FISH, and PCR in acute lymphoblastic leukemia: competing or complementary diagnostics? J Pediatr Hematol Oncol 31 930-935
[6]
Mullighan CG(2017)Cytogenetic nomenclature and reporting Methods Mol Biol 1541 303-309
[7]
Schultz KR(2018)Treatment and biology of pediatric acute lymphoblastic leukemia Pediatr Int 60 4-12
[8]
Pullen DJ(2019)Immunophenotypic dissection of normal hematopoiesis J Immunol Methods 475 112684-768
[9]
Sather HN(1996)Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms Am J Clin Pathol 105 761-357
[10]
Huret JL(2019)MLL-rearranged acute leukemia with t(4;11)(q21;q23)-current treatment options. Is there a role for CAR-T cell therapy? Cells 8 1341-133